您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > MS8815
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
MS8815
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
MS8815图片
CAS NO:2855085-25-3
包装与价格:
包装价格(元)
5mg电议
10mg电议

产品介绍
MS8815 是 zeste 同源物2(EZH2)PROTAC降解剂,具有选择性。MS8815 对 EZH2 有抑制活性,IC50值为 8.6 nM。MS8815 可用于三阴性乳腺癌 (TNBC) 研究。
生物活性

MS8815 is a selectiveenhancer of zeste homolog 2 (EZH2)PROTACdegrader. MS8815 has inhibition activity forEZH2with anIC50value of 8.6 nM. MS8815 can be used for the research of triple-negative breastcancer(TNBC)[1].

IC50& Target

IC50: 8.6 nM (EZH2); 62 nM (EZH1)[1].
DC50: 140 nM (EZH2 in MDA-MB-453 cells)[1]

体外研究
(In Vitro)

MS8815 shows potency in inhibiting the EZH2 and EZH1 methyltransferase activity with IC50values of 8.6 nM and 62 nM, respectively[1].
MS8815 (0.1-1 μM) degrades EZH2 with a DC50value of 140 nM in MDA-MB-453 cells[1].
MS8815 (1 μM; 48 h) induces robust EZH2 degradation in a concentration-, time-, and proteasome-dependent manner in TNBC cells[1].
MS8815 (0.1-10 μM; 5 days) effectively suppresses the cell growth in multiple TNBC cell lines and primary patient TNBC cells[1].

Western Blot Analysis[1]

Cell Line:MDA-MB-453 cells and BT549 cells
Concentration:0.3, 3 μM; 1μM
Incubation Time:48 h; 24 h
Result:Induced nearly complete degradation of EZH2 and exhibited the most robust degradation at 0.3 μM.
Induced EZH2 degradation in a time-and concentration-dependent manner.
Induced EZH2 degradation through the UPS.

Cell Proliferation Assay[1]

Cell Line:BT549, MDA-MB-468, SUM159 and MDA-MB-453 cells
Concentration:0.1-10 μM
Incubation Time:5 days
Result:Showed superior cellular growth inhibition activity in a panel of TNBC cells.
分子量

1154.51

Formula

C65H87N9O8S

CAS 号

2855085-25-3

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

溶解性数据
In Vitro: 

DMSO : 130 mg/mL(112.60 mM;Need ultrasonic)

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM0.8662 mL4.3308 mL8.6617 mL
5 mM0.1732 mL0.8662 mL1.7323 mL
10 mM0.0866 mL0.4331 mL0.8662 mL
In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: 10% DMSO    90%corn oil

    Solubility: ≥ 3.25 mg/mL (2.82 mM); Clear solution

    此方案可获得 ≥ 3.25 mg/mL (2.82 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。

    以 1 mL 工作液为例,取 100 μL 32.5 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。

*以上所有助溶剂都可在本网站选购。